Non-vitamin K Antagonist Oral Anticoagulant After Acute Coronary Syndrome: Is There a Role?
{{output}}
Despite dual antiplatelet therapy (DAPT) including potent P2Y12 inhibitors, recurrent ischaemic events occur in a significant number of patients after acute coronary syndrome (ACS), warranting new antithrombotic strategies. Combinations of non-vitamin K antago... ...
